Sorin strengthens lead business as financial shockwaves recede
This article was originally published in Clinica
Italian cardiovascular company Sorin has acquired OEM cardiac device firm Oscor’s lead business for $20m. The deal includes Tampa, Florida-based Oscor’s manufacturing facility in the Dominican Republic. Sorin was previously one of Oscor’s OEM clients, with the latter producing its MRI-compatible brady leads. The Italian firm believes the deal will allow further co-development opportunities for similar brady and tachy leads. For its part, Oscor will now focus on its catheters business and custom OEM lead development.